Exploring Ocular Adverse Events in Users of PDE5 Inhibitors
The use of PDE5 inhibitors increases the risk for serous retinal detachment, ischemic optic...
Read MoreApr 26, 2022
The use of PDE5 inhibitors increases the risk for serous retinal detachment, ischemic optic...
Read MoreNov 26, 2019
Use of criteria may substantially reduce the number of infants receiving eye exams
Read MoreNov 20, 2019
Hispanic children less likely to have had vision tested, as are children with public coverage, uninsured
Read MoreMay 2, 2019
Oral sedation found to be noninferior to IV sedation in terms of patient satisfaction
Read MoreMay 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gender Differences Seen in Adverse Drug Reactions FRIDAY, […]
Read More